CLPT compared with AUTL: revenue, margins and what each company keeps, and the suppliers and customers both name

CLPTClearPoint Neuro, Inc.

Mkt capRevenueRevenue

AUTLAutolus Therapeutics plc

Mkt capRevenueRevenue

Compare

CLPTClearPoint Neuro, Inc.

AUTLAutolus Therapeutics plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CLPT: latest quarter is a loss; flow not drawable. AUTL: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

CLPT, solidAUTL, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CLPT 0

None

Shared 0

No disclosed counterparties: CLPT.

Only AUTL 4

MRNAModernacustomer

BNTXBioNTechcustomer

—Miltenyi Biotec GmbHunlistedsupplier

—University College of London Businessunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CLPTClearPoint Neuro, Inc.

10.68▼−0.09%· post 10.97

Mkt cap$342.0MRevenue$12MQ3 FY26Revenue$37MFY25

AUTLAutolus Therapeutics plc

1.51▼−4.43%· post 1.51

ClosedOct 30 '26

Mkt cap$404.6MRevenue$46MQ2 FY26Revenue$75MFY25

Compare

ClosedOct 30 '26

CLPTClearPoint Neuro, Inc.

AUTLAutolus Therapeutics plc

10.68▼−0.09%post 10.97

Price

1.51▼−4.43%post 1.51

$342.0M

Mkt cap

$404.6M

Q3 FY26$12M

Revenue

$46MQ2 FY26

FY25$37M

Revenue

$75MFY25

CLPT10.68▼−0.09%vsAUTL1.51▼−4.43%ClosedOct 30 '26